Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 442,128 | 518,621 | 528,584 | 3,330 | -107,098 |
| Depreciation Amortization | 4,880 | 2,625 | 5,567 | 3,431 | 2,566 |
| Income taxes - deferred | N/A | N/A | 15,186 | N/A | N/A |
| Accounts receivable | 433,689 | -450,082 | -773,079 | -93,003 | N/A |
| Accounts payable and accrued liabilities | 2,444 | 3,829 | -171 | -959 | 4,933 |
| Other Working Capital | 590,548 | 3,914 | -628,394 | -17,449 | 72,669 |
| Other Operating Activity | 36,536 | 471,182 | 804,718 | 49,366 | 77,459 |
| Operating Cash Flow | $1,510,225 | $550,089 | $-47,589 | $-55,284 | $50,529 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -341,293 | -89,563 | -118,997 | 245,514 | 165,653 |
| PPE Investments | -36,428 | -15,829 | -21,817 | -8,746 | -2,744 |
| Investing Cash Flow | $-377,721 | $-105,392 | $-140,814 | $236,768 | $162,909 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -124 | N/A | N/A | -187 | N/A |
| Debt Repayment | N/A | -64 | -259 | N/A | -126 |
| Common Stock Issued | 32,086 | 28,946 | 100,590 | 94,848 | 91,158 |
| Other Financing Activity | -1,197 | -1,197 | 0 | 0 | 0 |
| Financing Cash Flow | $30,765 | $27,685 | $100,331 | $94,661 | $91,032 |
| Beginning Cash Position | 363,415 | 363,415 | 451,487 | 451,487 | 451,487 |
| End Cash Position | 1,526,684 | 835,797 | 363,415 | 727,632 | 755,957 |
| Net Cash Flow | $1,163,269 | $472,382 | $-88,072 | $276,145 | $304,470 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,510,225 | 550,089 | -47,589 | -55,284 | 50,529 |
| Capital Expenditure | -36,439 | -15,841 | -21,817 | -8,750 | -2,744 |
| Free Cash Flow | 1,473,786 | 534,248 | -69,406 | -64,034 | 47,785 |